administration of intravenous patient-controlled analgesia (IV PCA). However, opioids tend to be ineffective for pain that is associated with movement and have significant short-term side effects including nausea, vomiting, sedation, pruritus, constipation, urinary retention, and respiratory depression, 10 which are factors that often hinder a patient's recovery. Epidural analgesia has become an accepted alternative to IV PCA. Prospective randomized trials have found epidural analgesia to be superior to IV PCA in several surgical populations. [11] [12] [13] The physiologic effects of thoracic epidural anesthesia on the cardiovascular, respiratory, and gastrointestinal systems have been well documented. [14] [15] [16] Epidural analgesia works by inhibiting afferent impulses, blunting neuronal transmission from the periphery to the central nervous system and by inhibiting sodium channels at the level of the spinal cord. 15, 17 Two systematic reviews have demonstrated that epidural analgesia provides superior pain relief up to 72 hours after intra-abdominal surgery when compared to IV PCA. 18, 19 Studies have demonstrated that epidural analgesia is associated with fewer postoperative pulmonary complications and lower postoperative opioid consumption. 15, 16 The use of epidural analgesia has also been associated with early return of bowel function, a shorter length of stay in hospital, 15, 16, [20] [21] [22] enhanced functional exercise capacity, and better health-related quality of life. 23 Although effective postoperative pain management is of great importance to patients, there have been few reports documenting postoperative pain intensity after live liver donation. [24] [25] [26] One study, which compared patients who underwent right lobe donor hepatectomy with patients who had undergone major hepatic resection for tumor, found that patients who underwent RLDH had significantly more intense pain and were 2.76 times more likely to report increased pain at all postoperative time points. 24 Studies have prospectively examined postdonation changes in healthrelated quality of life after liver donation surgery. [27] [28] [29] Of these prospective studies, only 1 addressed postoperative pain, and the authors reported that the patient's anticipation of their postoperative pain was far worse than their actual experience of it. 28 The authors recommended further study of postoperative pain after live liver donation surgery. Despite the potential advantages of epidural analgesia, the risk of an extremely rare but significant complication such as an epidural hematoma has led several transplant centers to abandon the use of epidural analgesia. 1 However, there has been minimal published evidence with respect to epidural use in the live liver donor population. The abandonment of epidural use in this highly functioning population is a decision that should not be taken lightly. Detailed documentation of these patients' postoperative pain experiences and the effect of postoperative pain on their subsequent quality of life is an important outcome yet to be investigated.
The primary aim of this study was to examine difference in postoperative pain intensity and adverse effects between patients who received IV PCA or patient-controlled epidural analgesia (PCEA) for pain control after live liver donation surgery. A secondary aim was to determine whether postoperative complications and length of hospital stay differed significantly between patients that received IV PCA or PCEA.
PATIENTS AND METHODS
The study was reviewed and approved by the Research Ethics Board of the Toronto General Hospital, University Health Network, Toronto, Canada. We performed a retrospective analysis of pain intensity scores, analgesic consumption, and postoperative side effects after live liver donation. The Toronto General Hospital is a major liver transplant center, which performs more than 120-150 liver transplants annually. Live liver donation accounts for one-third of all organ transplants at our institution (150 of 490 transplants). Consecutive patients who had undergone elective RLDH surgery between April 2004 and January 2009 (n ¼ 226) were identified using institutional electronic databases. A total of 158 patients received IV PCA, and the other 68 patients received PCEA devices for control of postoperative pain. Prior to attending the preoperative anesthesia consultation clinic All patients had standard Canadian Anesthesiology Society monitors placed for surgery and were monitored using a radial arterial blood pressure transducer and internal jugular central venous pressure transducer. General anesthesia was induced using 1-2 mg/kg body weight of propofol, 1-2 lg/kg of fentanyl, and a nondepolarizing muscle relaxant to facilitate endotracheal intubation. The triple lumen central venous catheter was placed under ultrasound guidance (Sonosite; Bothell, WA). The central venous pressure was maintained between 2 and 6 mm Hg during liver resection. General anesthesia was maintained with a volatile anesthetic agent (isoflurane, sevoflurane, or desflurane). PCEA infusions were typically commenced within the first 2 hours after the start of surgery. For patients who were to receive IV PCA for postoperative pain control, intraoperative opioid boluses were given at the discretion of the attending anesthesiologist. For those patients who received epidural analgesia, epidural pumps were prepared by our postanesthetic care unit (PACU) on the morning of surgery and brought to the operating room. Typically, we do not receive the epidural pumps until patients are anesthetized and positioned for surgery. Other than the initial bolus of 3-5 mL of lidocaine into the epidural to confirm that the catheters were not intrathecal, boluses are kept to a minimum intraoperatively. The practice at our institution is to run the epidurals during the surgery because it also helps to decrease the central venous pressures, which helps to minimize blood loss. After surgery, all patients were extubated in the operating room or PACU. Shortly after arriving in the PACU, all patients were given a hand-held push-button that controlled the PCEA or IV PCA device, and recording of their analgesic consumption was begun. All patients were transferred to the surgical step-down ward upon discharge from the PACU.
The Acute Pain Service (APS) at the Toronto General Hospital has standardized algorithms for managing postoperative pain. Patients with thoracic epidurals placed below the T6 dermatome received a 0.1% bupivacaine solution with 0.015 mg/mL hydromorphone. The epidural infusion was delivered via an Abbott GemStar (Hospira, Lake Forest, IL) pump at a rate of 5 mL/hour (with a 3 mL bolus, 20-minute lockout period, and a 4-hour maximum of 50 mL). Patients in the PCEA group were not given IV opioids during the acute postoperative period. IV PCA was administered with an Abbott LifeCare PCA II (Hospira, Lake Forest, IL) pump using a hydromorphone concentration of 0.4 mg/mL boluses at a dose of 0.2-0.4 mg with a 5-minute lockout period and a 4-hour maximum of 10 mg or using a morphine concentration of 1 mg/mL boluses at a dose of 1.0-2.0 mg with a 5-minute lockout period and a 4-hour maximum of 40 mg. Patients received both hydromorphone and morphine IV PCA pumps. We converted opioid consumption use into morphine equivalents. The number of patients varies in Fig. 1 due to the inherent issues with retrospective reviews, because not all patients provided data at every time point. Acetaminophen is not prescribed to living related donors until the surgeons are comfortable with liver function. Nonsteroidal antiinflammatory drugs are also not routinely prescribed in the early postoperative period.
Pain intensity was measured with a numeric rating scale (NRS). The NRS consists of a series of numbers ranging from 0 to 10 with endpoints representing the most extreme pain experiences (0 ¼ no pain and 10 ¼ worst possible pain). The NRS has been shown to have good reliability and validity and is sensitive to change following pharmacological intervention. 30 Clinically significant moderate pain is defined as a score greater than 4 out of 10, with severe pain being reported as pain greater than 6 out of 10 on the NRS. 31, 32 Pain intensity was measured using the NRS every 4 hours by the attending nursing staff following surgery until discharge from the APS. The APS reviewed each patient a minimum of 2 times per day while the epidural was in situ and once per day while the IV PCA was in use. If patients reported a pain score equal to or greater than 5 of 10 on 2 consecutive time points (after having been assessed by the ward nurse and deemed to be using the PCEA or IV PCA device adequately), the patient's attending nurse paged the APS physician, who then visited the patient and adjusted the epidural rate or the IV PCA settings as needed to ensure patient comfort.
Data from the postoperative period was manually obtained from the scanned version of the paper chart, including APS records (ie, postoperative analgesic mode [IV PCA versus PCEA], pain intensity scores, volume of epidural solution infused, opioid consumption, side effects [sedation, pruritus, nausea, and vomiting] and the duration of patient care by the APS), physiotherapy notes (day of ambulation), nursing documentation records (diet advancement), and drug administration record (supplemental analgesic use). Data were obtained at specific daily time points of 06:00, 12:00, 18:00, and 24:00 when under the care of the APS. Pain scores were collected from postoperative day (POD) 0 (day of surgery) until patients were discharged from the APS. Demographic information including sex, age, height, and weight were also recorded from the electronic records. All patients received an American Society of Anesthesiologists classification score of 1 or 2.
The presence or absence of sedation, nausea, vomiting, and pruritus was recorded from the electronic records. We also recorded the time to achieve initial ambulation, when oral fluid intake first occurred, and the date of hospital discharge.
Statistical Analysis
The primary outcome variable of interest was pain intensity scores across the first 3 days after surgery. For each patient, we computed 2 measures of area under the pain curve (AUPC): (1) Time 1: from POD0 18:00 to POD1 24:00 (total of 6 time points covering 30 hours) (2) Time 2: from POD1 24:00 to POD3 06:00 (total of 6 time points covering 30 hours). In computing the AUPC, patients were excluded if they (1) had more than 2 pain scores missing during the time period or (2) were missing pain scores for 2 or more consecutive time points. For the remaining patients, missing pain scores were imputed by calculating the mean of the pain scores of the adjacent time points.
For the comparison of AUPC values between the 2 treatment groups, the analysis was adjusted for potential confounding factors. This was particularly important because the study was not a randomized controlled trial and potential biases between the groups were therefore minimized by statistically controlling for age, sex, and surgeon via stratification using the nonparametric Aligned Rank test. 33 This test is known to be more powerful than the van Elteren test. 34 For the stratification according to age, the data were dichotomized based on the median age value. For the comparison of adverse events, the data were dichotomized representing presence or absence of sedation, nausea, vomiting, and pruritus.
Demographic and clinical variables were compared between the two groups using Wilcoxon test for continuous (or ordinal) variables and Fisher's exact test for categorical variables. All calculations were performed using SAS statistical software package version 9.2 (SAS Institute, Inc., Cary, NC) and R software environment version 2.10 (The R Foundation for Statistical Computing, Vienna, Austria), under the Microsoft Windows XP Professional (version 2002, Service Pack 3; Microsoft Corp., Redmond, WA) operating system. 35 
RESULTS
The patients receiving postoperative epidural analgesia and those receiving IV PCA were similar with respect to age, sex, and body mass index. Patients who chose IV PCA for postoperative pain control received significantly more intraoperative opioids than patients who opted for a PCEA (P < 0.001; Table 1) . Figure 1 shows the NRS pain scores across the 2 time periods as well as the IV PCA and PCEA groups' consumption of analgesics/epidural solution. Overall, postoperative pain was better controlled with the use of epidural analgesia. The AUPC was significantly smaller in patients who received PCEA versus IV PCA throughout both Time 1 (P < 0.00005) and Time 2 (P ¼ 0.019). The analysis shows that postoperative pain was significantly less intense from POD0 to the morning of POD3 for patients who received epidural analgesia as their primary pain modality. In order to control for possible bias within this retrospective database, a secondary analysis of pain scores which were stratified for age, sex, and surgeon also demonstrated that the AUPC was significantly smaller in patients who received PCEA versus IV PCA for both Time 1 (P < 0.0001 all time points) and Time 2 (P ¼ 0.05 all time points; Table 2 ).
Pain Scores

Clinically Significant Moderate Pain
Clinically significant moderate pain, defined as an NRS score greater than 4, 31 was reported significantly less often in the epidural group than the IV PCA group at POD0 24:00 (P < 0.01), POD1 06:00 (P < 0.05), POD1 12:00 (P < 0.05), and POD1 24:00 (P < 0.01; Table 3 )
Adverse Effects
Sedation was present more often in the IV PCA group when compared to patients who received PCEA at various time points until the morning of POD3 (Table 4) . The reported incidence of pruritus was higher in the PCEA group (Table 5) . Patients who received PCEA also demonstrated a higher incidence of nausea on the morning of POD3 (Table 6) . Vomiting rarely occurred, and the incidence did not differ significantly between the groups. Table 7 demonstrates that significant intergroup differences were not found with respect to the time that oral fluid intake was initiated, the time to initial ambulation, or the length of hospital stay. 
Hospital-Based Outcomes
DISCUSSION
Given the excellent health status and high functional disposition of live liver donors, the pain experienced upon awakening from surgery is often the patient's first experience with significant pain. Throughout the early postoperative time period, patients using IV PCA devices reported significantly more intense pain compared to patients who received PCEA (Fig. 1) . Although the mean pain scores depicted in Fig. 1 are by and large below an NRS score of 3, we further examined each time point with respect to the number of patients who reported moderate pain (ie, NRS > 4 out of 10). 36 The NRS cut-point corresponding to the transition from mild to moderate pain occurs when a patient reports a pain score greater than 4 out of 10; the cut-point for moderate to severe pain corresponds to an NRS pain score greater than 6 out of 10.
31,32,37 Table 3 demonstrates that until POD2, significantly more patients in the IV PCA group reported more clinically significant postoperative pain (ie, reported pain scores greater than 4 out of 10) than did patients in the PCEA group. Severe pain was a very rare occurrence in both groups. Given that the P value for Time 2 (P ¼ 0.019) in Fig. 1 demonstrates less overall significance than the P value of Time 1 (P < 0.00005), we accept the criticism that the difference in postoperative pain demonstrated at Time 2 may or may not be of clinical significance. The significant between group difference in intraoperative opioid administration (Table 1 ) may have also contributed to the greater postoperative pain scores in the IV PCA group. Evidence shows that opioids, such as fentanyl, paradoxically activate pronociceptive systems associated with acute opioid tolerance and opioid-induced hyperalgesia. [38] [39] [40] [41] Thus, it is possible that the more intense pain in the IV PCA group may be due, in part, to the greater systemic dose of intraoperative opioids, in particular fentanyl.
The limited literature evaluating the effect of different modes of postoperative analgesia among live liver donors is not surprising because this surgery has a relatively short history. Yong and colleagues found no difference in the intensity of postoperative pain between those receiving epidural analgesia when compared to those receiving IV PCA. 25 Cywinski and colleagues demonstrated that live liver donor patients had more significant pain as compared to patients with liver malignancies. 24 The authors attributed the lack of adequate pain control in the live donors to the increased surgical time and to the lack of appropriate nursing care/knowledge with respect to the PCEA devices. 24 Millions of patients undergo surgery on an annual basis in North America to remedy diseased states. 42 However, surgery for living organ donation is different in many respects. Healthy patients subject themselves to an otherwise unnecessary surgery for an altruistic cause. Although every aspect of the donor surgery is important, the patient's postoperative pain experience should not be overlooked. Patients' experiences in the immediate postoperative period often shape their recovery trajectories, their ability to resume normal activities, and their willingness to recommend live liver donation to other healthy, highly functioning individuals. A painful experience could conceivably limit a patient's willingness to recommend this altruistic act to others who may be considering potential liver donation. 43 Given that previous studies have demonstrated a higher incidence of postoperative pain than patients had anticipated, [43] [44] [45] this aspect of the liver transplant experience demands future attention.
Epidural analgesia is extremely safe; however, the literature does report a very low risk of patients developing an epidural hematoma (ie, 1:150,000 patients). 46, 47 Although epidural hematomas are extremely rare, the consequences can be catastrophic with paralysis as the result. Postoperative coagulopathy can occur in a subset of patients (manifested as a transient prolongation of international normalized ratio and prothrombin times), 48 which could potentially increase the risk of developing an epidural hematoma, although to our knowledge, there have been no published reports of epidural hematomas after live liver donor surgeries. Unfortunately, the very rare incidence of an epidural hematoma precludes the study of this adverse event in a prospective trial. A report that reviewed the use of epidural analgesia for live liver donors found that although the coagulation profiles were abnormal in some patients, values returned to baseline by POD3 and there were no reports of epidural hematomas. 48 At our institution, of the 226 live liver donor operations analyzed, only 68 patients received epidural analgesia as their primary analgesic modality. This general trend is not surprising given the reluctance of the perioperative team to expose such highly functioning patients to the risk of a catastrophic event. In recent years, epidural analgesia has become more popular with anesthesiologists for hepatic carcinoma resections. 24, 49 Clearly, the safety of epidural analgesia after live liver donation requires further study.
Animal models have demonstrated that acute hepatic failure causes increased plasma levels of systemic opioids 50 ; therefore, sedation following liver resection may be an early sign of liver insufficiency. Table 1 demonstrates that patients without PCEA received significantly more opioids intraoperatively, which most likely added to the increased sedation found at POD0 18:00 (Table 4 ). However, beyond that initial time point, the increased interval opioid usage by the IV PCA group is presented in Fig. 1 and is congruent with the increased sedation demonstrated by this group in Table 4 . Our current results are supported by a previous study that also found that the use of PCEA for primary pain relief after liver resection has reduced the amount of systemic opioids administered to patients by more than 50%. 51 The increased incidence of pruritus (Table 5) reported by the PCEA group can be improved by removing the opioid from our epidural solutions. Furthermore, the use of an opioid-free epidural may not only offer excellent pain control, it may also reduce side effects and should not affect liver function or the ability of the transplant team to detect early liver insufficiency.
There are several limitations to our retrospective analysis. First, given the retrospective nature of the data collected, adequate standardization of postoperative care was unlikely. Second, coagulation profiles of our patients were not collected because it was not one of the aims of our study. Limited coagulation profile data, even if collected in our population, would likely be insignificant with respect to determining the risk of perioperative bleeding and the potential risks associated with the development of an epidural hematoma. Finally, pain data were not available after patients were discharged from the APS.
The results of this study demonstrate that the use of PCEA significantly reduces moderate pain in the early postoperative period among patients who had undergone living donor hepatectomy when compared to use of IV PCA. Significant pain relief was noted up to the morning of postoperative day 3. Ongoing research is being conducted by the Adult to Adult Living Donor Liver Transplantation (A2ALL) Consortium with respect to long-term health-related quality of life after live liver donation. It is imperative that the following aspects of live liver donation surgery be thoroughly investigated: pain experience, the potential risks/benefits of epidural analgesia relative to other analgesic modalities, and that the physical, psychological, and long-term effects on the functioning of these patients continue to be documented. The remote possibility of the occurrence of an epidural hematoma is not sufficient rationale to dismiss this modality of pain control for all patients undergoing live liver donation. Collecting data in a prospective manner would help to validate or refute the current results and improve patient preoperative awareness and informed consent for live liver donation. Data are mean 6 SD. Significant differences were not found between groups.
